Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vigil Neuroscience, Inc. - Common Stock (NQ: VIGL ) 3.510 +0.130 (+3.85%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vigil Neuroscience, Inc. - Common Stock < Previous 1 2 3 4 5 Next > Vigil Neuroscience to Present at Stifel 2024 Virtual CNS Days March 12, 2024 From Vigil Neuroscience, Inc. Via GlobeNewswire Vigil Announces Oral Presentation on Small Molecule TREM2 Agonist VG-3927 as a Potential Disease-Modifying Therapeutic at AD/PD 2024 March 06, 2024 Presentation highlights potential for VG-3927 to treat neurodegenerative diseases associated with microglial dysfunction, like AD, due to its differentiated neuroprotective profile and ability to... From Vigil Neuroscience, Inc. Via GlobeNewswire Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ACTRIMS 2024 February 29, 2024 From Vigil Neuroscience, Inc. Via GlobeNewswire Vigil Neuroscience to Present at Guggenheim 6th Annual Biotechnology Conference February 07, 2024 From Vigil Neuroscience, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session January 08, 2024 Via Benzinga Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones January 03, 2024 From Vigil Neuroscience, Inc. Via GlobeNewswire Vigil Neuroscience to Present at Evercore ISI 6th Annual HealthCONx Conference November 22, 2023 From Vigil Neuroscience, Inc. Via GlobeNewswire Why Is Rare Neurological Disease Focused Vigil Neuroscience Stock Trading Lower Today? November 17, 2023 Vigil Neuroscience Inc (NASDAQ: VIGL) shares are down after the company released interim data from its Phase 2 IGNITE proof-of-concept clinical trial in patients with adult-onset leukoencephalopathy... Via Benzinga Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session November 17, 2023 Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session November 17, 2023 Via Benzinga US Stocks Edge Lower; Housing Starts Rise In October November 17, 2023 U.S. stocks traded slightly lower this morning, with the Nasdaq Composite falling around 30 points on Friday. Following the market opening Friday, the Dow traded down 0.04% to 34,931.47 while the... Via Benzinga Topics Stocks Exposures US Equities Vigil Neuroscience Reports Positive Interim Data from Phase 2 IGNITE Proof-of-Concept Clinical Trial Evaluating Iluzanebart (VGL101) as a Treatment for ALSP and from Ongoing Natural History Study ILLUMINATE November 16, 2023 From Vigil Neuroscience, Inc. Via GlobeNewswire Vigil Neuroscience Reports Third Quarter 2023 Financial Results and Provides Business Update November 07, 2023 From Vigil Neuroscience, Inc. Via GlobeNewswire Vigil Neuroscience's Focus On Neurodegenerative Diseases: Analyst Says Pipeline Offers Upside Opportunities To Valuation October 18, 2023 JMP Securities has initiated coverage on Vigil Neuroscience Inc (NASDAQ: VIGL), noting the company's focus on neurodegenerative diseases. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023 October 18, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session October 17, 2023 Via Benzinga Vigil Neuroscience Announces First Participant Dosed in Phase 1 Clinical Trial in Healthy Volunteers Evaluating VG-3927, a Small Molecule TREM2 Agonist, for Potential Treatment of Alzheimer’s Disease October 17, 2023 From Vigil Neuroscience, Inc. Via GlobeNewswire Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session October 06, 2023 Gainers Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session October 06, 2023 Via Benzinga Vigil Neuroscience to Present at Jefferies Inaugural Biotech CNS/Neuro Summit October 05, 2023 From Vigil Neuroscience, Inc. Via GlobeNewswire Vigil Neuroscience Receives Positive Opinion from European Medicines Agency on Orphan Drug Designation for VGL101 for the Treatment of ALSP September 26, 2023 From Vigil Neuroscience, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session September 21, 2023 Via Benzinga Vigil Neuroscience Presents VGL101 Complete Phase 1 Data and Phase 2 IGNITE Trial Design at the 2023 American Neurological Association Annual Meeting September 11, 2023 From Vigil Neuroscience, Inc. Via GlobeNewswire Vigil Neuroscience Announces Update on its Small Molecule TREM2 Agonist Program September 08, 2023 From Vigil Neuroscience, Inc. Via GlobeNewswire Vigil Neuroscience to Present at 2023 Morgan Stanley Global Healthcare Conference September 08, 2023 From Vigil Neuroscience, Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Wednesday August 09, 2023 On Wednesday, 155 companies set new 52-week lows. Via Benzinga Vigil Neuroscience Reports Second Quarter 2023 Financial Results and Provides Business Update August 08, 2023 From Vigil Neuroscience, Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Thursday September 07, 2023 On Thursday, 283 companies set new 52-week lows. Via Benzinga Vigil Neuroscience Appoints Christopher J. Silber, M.D. as Chief Medical Officer August 07, 2023 From Vigil Neuroscience, Inc. Via GlobeNewswire Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus July 13, 2023 Regulatory filings show Gilead Sciences' purchase of shares in AlloVir and Arcus. Strategic investments in the biotech sector are fairly common to boost growth. Via MarketBeat Topics Retirement Exposures Pension < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.